Tumor stroma ratio as a parameter for prognosis and clinicopathological behavior of oral squamous cell carcinoma: A retrospective cohort study

Abstract

Background and aim: Tumor-stroma ratio (TSR) is the proportion of tumor cells to surrounding stroma. TSR was reported in many carcinomas as an independent strong, prognostic parameter, and could be applied routinely in diagnostic pathology. This study aimed to clarify the association between prognosis and TSR of oral squamous cell carcinoma (OSCC) and to evaluate its correlations with the clinical stages and histological grades of the studied cases. Materials and Methods: One hundred thirty-nine anti-vimentin stained slides were digitized and analyzed for TSR scoring. TSR was classified as stroma rich (< 50%) and stroma poor ( $\ge 50\mathrm{\%}$ ). Correlations between clinicopathological variables and TSR were assessed. Results: Microscopical examination of the studied cases revealed that 67(48.2%) were stroma-rich and 72(51.8%) were stroma-poor. Overall findings explained that stroma rich group had larger size, higher clinical stage, higher recurrence rate with a low disease free survival (DFS) and worse overall survival (OS) than the stroma poor. Conclusion: The clinical outcomes of stroma rich OSCC is poor as it is associated with decreased OS and DFS of patients. Hence, TSR may be used as a prognostic independent factor for OSCC and thus, TSR can be considered as an important, low cost and valuable parameter that could be used in addition to the TNM status. Moreover, TSR might be helpful for the judgment of prognosis and for the determination of OSCC high-risk patients to treat them individually.

Keywords

TSR / SCC / Vimentin / OSCC prognosis

Conflicts of Interest Disclosure

No potential conflicts of interest are disclosed.

References

[1] Del CG, Villa A, Tarsitano A, et al. Current trends in oral cancer: a review. Can Cell Microenviron. 2016; 3: e1332.

[2] Arcangeli A, Crociani O, Bencini L. Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer. Philos Trans R SocLond B Biol Sci. 2014; 369(1638): 20130101. PMid:24493749. https://doi.org/ 10.1098/rstb. 2013.0101

[3] van Pelt GW, Sandberg TP, Morreau H, et al. The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact. Histopathology. 2018; 73(2): 197-206. PMid:29457843. https: //doi.org/10.1111/his. 13489

[4] Wu J, Liang C, Chen M, et al. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis. Oncotarget. 2016; 7(42): 68954-68965. PMid:27661111. https://doi.org/10.18632/oncotarget. 12 135

[5] Aurello P, Berardi G, Giulitti D, et al. Tumor-Stroma Ratio is an independent predictor for overall survival and disease free survival in gastric cancer patients. Surgeon. 2017; 15(6): 329-335. PMid:28629870. https://doi.org/10.1016/j.surge.2017.05.007

[6] van Pelt GW, Kjær-Frifeldt S, et al. Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations. Virchows Arch. 2018; 473(4): 405-412. PMid:30030621. https://doi.org/10.1007/s00428-018-2408-z

[7] Vangangelt KMH, van Pelt GW, Engels CC, et al. Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma. Breast Cancer Res Treat. 2018; 168(3):601-612. PMid:29273955. https://doi.org/10.1007/s10549 -017-4617-6

[8] Lee D, Ham IH, Son SY, et al. Intratumor stromal proportion predicts aggressive phenotype of gastric signet ring cell carcinomas. Gastric Cancer. 2017; 20(4): 591-601. PMid:27858181. https: //doi.org/10.1007/s10120-016-0669-2

[9] Zhou ZH, Ji CD, Zhu J, et al. The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer. J Cancer Res ClinOncol. 2017; 143(5): 883-894. PMid:28180998. https://doi.org/10.1007/s00432-017-2346-1

[10] Mesker WE, Junggeburt JM, Szuhai K, et al. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol. 2007; 29(5): 387-398. PMid:17726261. https://doi.org/10.1155/2007/1 75276

[11] Liu J, Li J, Chen Y, et al. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma. GynecolOncol. 2014; 132(1): 81-86. PMid:24219981. https://doi.org/10.1016/j. ygyno. 2013. 11.003

[12] Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res. 2007; 86(2): 104-114. PMid:17251508. https://doi. org/10. 1177/154405910708600202

[13] Pires FR, Ramos AB, Oliveira JB, et al. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period. J Appl Oral Sci. 2013; 21(5): 460-467. PMid:24212993. https://doi.org/10. 1590/16 79-775720130317

[14] Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young peoplea comprehensive literature review. Oral Oncol. 2001; 37(5): 401-418. https://doi.org/10.1016/S1368-8375(00)00135-4

[15] Torossian JM, Beziat JL, Philip T, et al. Squamous cell carcinoma of the tongue in a 13-year-old boy. J Oral Maxillofac Surg. 2000; 58(12): 1407-1410. PMid:11117690. https://doi.org/10. 105 3/joms.2000.18276

[16] Zedan W, Mourad MI2, El-Aziz SM3, et al. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma. DiagnPathol. 2015; 10: 2. PMid:25881131. https://doi.org/10.1186/s13000-015-0 232-1

[17] Haq MEU, Abid H, Hanif MK, et al. Frequency and Pattern of Oral and Maxillo-facial Carcinomas. J Orofacial Res Ann. 2009; 15(4): 171-175.

[18] Manuel S, Raghavan SK, Pandey M, et al. Survival in patients under 45 years with squamous cell carcinoma of the oral tongue. Int J Oral Maxillofac Surg. 2003; 32(2): 167-173. PMid:12729777. https://doi.org/10.1054/ijom.2002.0271

[19] Okada Y, Mataga I, Katagiri M, et al. An analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma. Relationship between grade of histopathological malignancy and lymph nodes metastasis. Int J Oral Maxillofac Surg. 2003; 32(3): 284-288. PMid:12767876. https://doi.org/10.1054/ijom. 2002.0303

[20] Shah I, Sefvan O, Luqman U, et al. Clinical stage of oral cancer patients at the time of initial diagnosis. J Ayub Med Coll Abbottabad. 2010; 22(3): 61-63.

[21] Miyagi J, Tsuhako K, Kinjo T, et al. Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J ClinPathol. 2000; 53(9): 676-684. PMid:11041057. https://doi.org/10.1136/jcp.53.9.676

[22] Yanofsky VR, Mercer SE, Phelps RG. Histopathological variants of cutaneous squamous cell carcinoma: a review. J Skin Cancer. 2011;2011: 210813. PMid:21234325. https://doi.org/10.1155/20 11/210813

[23] Ueda C, Uchiyama T, Ohno H.Immunoglobulin (Ig)/BCL6 versus non-Ig/BCL6 gene fusion in diffuse large B-cell lymphoma corresponds to a high-versus low-level expression of BCL6 mRNA. Blood. 2002; 99(7): 2624-2625. PMid:11926184. https://doi.org/10.1182/blood-2001-11-0117

[24] Wang K, Ma W, Wang J, et al. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. J ThoracOncol. 2012; 7(9): 1457-1461. PMid:22843085. https://doi.org/10.1097/JTO.0b013e318260dfe8

[25] Zhang T, Xu J, Shen H, et al. Tumor-stroma ratio is an independent predictor for survival in NSCLC. Int J ClinExpPathol. 2015; 8(9): 1348-55. eCollection 2015.

[26] Zhu QC, Gao RY, Wu W, et al. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev. 2013; 14(5): 2689-98. PMid:23803016. https: //doi.org/10.7314/APJCP.2013.14.5.2689

[27] Madar S, Goldstein I, Rotter V. Cancer associated fibroblasts'more than meets the eye. Trends Mol Med. 2013; 19(8): 447-453. PMid:23769623. https://doi.org/10.1016/j.molmed.2013. 05.0049

[28] Pietras K, Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010; 316(8): 1324-1331. PMid:20211171. https://doi.org/10.1016/j.yexcr.2010.0 2.045

[29] Kawashiri S, Tanaka A, Noguchi N, et al. Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck. 2009; 31(10): 1346-1353. PMid:19373786. https://doi.org/10. 100 2/hed. 21097

[30] Massagué J. TGFbeta in Cancer. Cell. 2008; 134(2): 215-230. PMid:18662538. https://doi.org/10.1016/j.cell.2008.07. 001

[31] Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007; 121(1): 1-14. PMid:17386080.https://doi.org/10.1111/j.1365-2567.20 07.02587.x

[32] Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem. 2007; 101(4): 805-815. PMid:17226777. https://doi.org/10.1002/jcb. 21159

[33] Schottelius AJ, Dinter H. Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer. Cancer Treat Res. 2006; 130: 6787. PMid:16610703. https://doi.org/10.1007/0-387-26283 -0_3

[34] Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006; 6(5): 392-401. PMid:16572188. https://doi.org/10.1038/nr c1877

[35] De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol. 2003; 200(4): 429-447. PMid:12845611. https: //doi.org/10.1002/path. 1398

[36] Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009; 9(4): 274-284. PMid:19308067. https://doi.org/10.1038/nrc2622

[37] Haq MEU, Abid H, Hanif MK, et al. Frequency and Pattern of Oral and Maxillo-facial Carcinomas. J Orofacial Res Ann. 2009; 15(4): 171-175.

[38] Bremnes RM, Dønnem T, Al-Saad S, et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinomaassociated fibroblasts and non-small cell lung cancer. J ThoracOncol. 2011; 6(1): 209-217. PMid:21107292. https://doi.org/10. 109 7/JTO.0b013e3181f8a1bd